Indeed, 70% of the AML samples tested showed an increase in AKT phosphorylation after long-term exposure to inhibitors; this increase was related to an upregulation of IRS1 expression and IR, IGF1R and PDGFR phosphorylation. The gene discussed is AKT1; the disease is acute myeloid leukemia.